Zdrowie i gospodarka · 18.10.1994
Cooperative Research and Development Agreement
The Centers for Disease Control and Prevention (CDC), National Center for Infectious Diseases, announces the opportunity for potential collaborators to enter into a Cooperative Research and Development Agreement (CRADA) for the refinement and commercialization of a sensitive and specific assay for the detection of reverse transcriptase in a variety of sample types. It is anticipated that this and any new technologies or inventions which may arise from this CRADA will be licensed to the collaborator with whom the CRADA is made. Because CRADAs are designed to facilitate the development of scientific and technological knowledge into useful, marketable products, a great deal of freedom is given to Federal agencies in implementing collaborative research. The CDC may accept staff, facilities, equipment, supplies, and money from the other participants in a CRADA. CDC may also provide staff, facilities, equipment, and supplies to the project. There is a single restriction in this exchange: CDC MAY NOT PROVIDE FUNDS to the other participants in a CRADA. This opportunity is available until 30 days after publication of this notice. Respondents may be provided a longer period of time to furnis